Viewing Study NCT02013128


Ignite Creation Date: 2025-12-26 @ 11:14 AM
Ignite Modification Date: 2026-02-21 @ 9:03 AM
Study NCT ID: NCT02013128
Status: COMPLETED
Last Update Posted: 2022-10-24
First Post: 2013-12-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ublituximab + Ibrutinib in Select B-cell Malignancies
Sponsor: TG Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
None Mantle Cell Lymphoma View
Keywords: